Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Dr. Manjeet Mehta

Dr. Manjeet Mehta

GENETIC WORLD, Molecular Genetics Laboratory, India

Title: Advances in our understanding of Human Genome, and how it has changed the way we diagnose, prevent & treat disease.

Biography

Biography: Dr. Manjeet Mehta

Abstract

Genetics is the basic science for biology and medicine. This truth is getting wider acceptance by the medical community as nowadays any disease of any system, monogenic to multifactorial and infectious disease to cancers, needs a molecular diagnosis. There is extensive use of cytogenetic and molecular genetic techniques in cancer diagnostics, prognostication and treatment. The importance of genetic testing is accepted by clinicians as has been well proved. There is a great need of better understanding of the genetic aspects of birth defects and principles of genetic techniques so that genetic testing can be appropriately used for the benefit of evaluation of fetal anomalies and providing genetic counseling and prenatal diagnosis to the families. Genomic techniques which can analyze the whole genome in one go have made genetic testing easier and the techniques of microarray and exome/genome sequencing are being applied in clinical situations more and more frequently. It has become practically the first-tier test for most of the genetic disorders by exome sequencing for neurogenetic disorders. The cost of this latest technological marvel is within the reach of many families and the costs are likely to come down further. There are some interesting issues about next generation sequencing in medicine. Also, there is importance of knowing the significance of each nucleotide in the genome, so that the exome sequencing data can be analyzed in a more meaningful manner and with more confidence. As more and more exomes are sequenced, more and more data about pathogenic and polymorphic sequence variations is getting accumulated and these comprehensive databases will ease the challenging task of genome/exome analysis to some extent. The whole objective of diagnosis is finding a path towards curative treatment. So, at this juncture, when the clinicians are gradually getting prepared for molecular medicine, the scientific community is putting together some more pieces of the extremely complex puzzle of human physiology and pathology using genomic techniques. Medicine will take some big leaps in the next decade or two